Health‐related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors—Results from the HAVEN 2 study

INTRODUCTION: Persons with haemophilia A (PwHA) with factor (F)VIII inhibitors, including children, have impaired health‐related quality of life (HRQoL). The HAVEN 2 study (NCT027955767) of paediatric PwHA with FVIII inhibitors demonstrated that subcutaneous emicizumab prophylaxis resulted in low an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancuso, Maria Elisa, Mahlangu, Johnny, Sidonio, Robert, Trask, Peter, Uguen, Marianne, Chang, Tiffany, Shima, Midori, Young, Guy, Oldenburg, Johannes, von Mackensen, Sylvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821108/
https://www.ncbi.nlm.nih.gov/pubmed/33084175
http://dx.doi.org/10.1111/hae.14183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821108/
https://www.ncbi.nlm.nih.gov/pubmed/33084175
http://dx.doi.org/10.1111/hae.14183

Ejemplares similares